This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,440.62 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with an ultimate completion date of December 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order for diabetes management medication is one of the many critical medical commodities, including specialty drugs, vaccines, and medical devices, that AmerisourceBergen provides to federal agencies through its extensive supply chain and distribution capabilities.
Generated 3/21/25, 10:00 AM